Knight Therapeutics Inc. GUD.TO
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · TSX · Canada · knighttx.com
Knight Therapeutics Inc. is a pan-American specialty pharmaceutical company focused on acquiring, in-licensing, and commercializing innovative prescription pharmaceuticals in Canada and Latin America. The company operates in Canada and 10 Latin American countries with over 700 employees globally, generating the majority of its revenue from Brazil. Knight is headquartered in Montreal, Quebec.
Key ratios
CashFromOperationsYoYGrowth TTM 10.69
CashFromOperationsYoYGrowth 2025 0.9
CashFromOperationsYoYGrowth 2024 0.01
CashFromOperationsYoYGrowth 2023 -0.2
DilutedEPSYoYGrowth TTM -0.43
FreeCashFlowOnSale TTM 0.2
FreeCashFlowOnSale 2025 0.15
FreeCashFlowOnSale 2024 0.09
FreeCashFlowOnSale 2023 0.11
NetIncomeMargin TTM 0.01
NetIncomeMargin 2025 -0.01
NetIncomeMargin 2024 0.01
NetIncomeMargin 2023 -0.05
ReturnOnAssets TTM 0.01
ReturnOnAssets 2025 -0
ReturnOnAssets 2024 0
ReturnOnAssets 2023 0
ReturnOnEquity TTM 0.01
ReturnOnEquity 2025 -0.01
ReturnOnEquity 2024 0.01
ReturnOnEquity 2023 -0.02
TotalRevenueYoYGrowth TTM 0.37
TotalRevenueYoYGrowth 2025 0.21
TotalRevenueYoYGrowth 2024 0.13
TotalRevenueYoYGrowth 2023 0.12
Recent news
Notice of Knight Therapeutics' Second Quarter 2026 Results Conference Call
2026-07-30 · GlobeNewswire
Knight Therapeutics Announces Repayment of Revolving Credit Facility
2026-06-17 · GlobeNewswire
Knight Announces Early Warning Filing Regarding Shares of Crescita
2026-06-05 · GlobeNewswire